Money talks and BS walks. The FDA is not likely to ever approve Coxavin or any other vaccine that competes against BIG PHARMA. OCGN will have to make their mark outside of the US until POSSIBLY somewhere down the road public concensus or Legislation turns the tide. Possible but not Probable. Like Vegas, It is hard to beat the house. The truth is a hard pill to swallow. GLTA
Market Data 
Markets 
AI
